Singular Wings Medical has developed deep learning algorithms with AI, cloud-based platform to facilitate off-site diagnoses, effectively extending medical support beyond the confines of traditional hospital settings. These algorithms contribute to diverse medical solutions including post-operative cardiac rehabilitation, sleep apnea management, and non-invasive glucose monitoring. Our cloud-based monitoring platform enables real-time monitoring of patients' physiological parameters. This dynamic platform detects abnormal vital signs, such as arrhythmias, irregular breathing patterns, and fluctuations in blood glucose levels, promptly issuing alerts to ensure timely intervention. By harnessing the power of this integrated solution, healthcare practitioners are empowered with the ability to gain real-time insights into patients' physiological conditions, thereby fostering an environment conducive to precise and informed diagnostic assessments.
We are looking for business partners as,
1. Agents, distributors, and investors
2. Service providers who are looking for integration of our Cloud Service/API, Device, and SDK
3. A proof of concept (PoC) from hospital, clinical research/trials
4. Enterprises enter and be stationed in field (virtual)
5. Medical device regulatory consulting services, lawyers for legal advice
6. Association of digital health, medical and telehealth
Singular Wings Medical contributes to AI medical solutions and created an AI-based healthcare system working on big data, machine learning, AI algorithm. We set up our first US company, meanwhile a subsidiary has been established in Vilnius, Lithuanian as our first step to the EU market.
Name:
Phone:
Address:11F., No. 257, Wenxing Rd., 302050, Zhubei City, Hsinchu County, Taiwan
Ultrahigh-Sensitive Detection Platform Powered by Semiconductor-based Biosensor for the evaluation of Treatment on Acute Myeloid Leukemia
A Wearable and Self-powered Multifunctional Module for Active Infectio n Prevention, Accelerated Wound Healing and Noninvasive Healing Moni toring
One Model Fit All: Revolutionary One-Stop Shop System for Predicting Co ronary Stenosis without Normal Database in Myocardial Perfusion Imagin g
Platform for Oligonucleotide Drug Production (Nucleic Acid Drugs for the Treatment of Pulmonary Fibrosis)
Technology maturity:Mass production
Exhibiting purpose:Display of scientific results、Product promotion
Trading preferences:Technical license/cooperation、Negotiate by self
Coming soon!